• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19

tetano

Editor, Senior Moderator
Respir Investig


. 2023 Apr 19;61(4):454-459.
doi: 10.1016/j.resinv.2023.03.007. Online ahead of print. Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19

Takuya Ozawa[SUP] 1 [/SUP], Takanori Asakura[SUP] 2 [/SUP], Shotaro Chubachi[SUP] 1 [/SUP], Ho Namkoong[SUP] 3 [/SUP], Hiromu Tanaka[SUP] 1 [/SUP], Ko Lee[SUP] 1 [/SUP], Takahiro Fukushima[SUP] 1 [/SUP], Shiro Otake[SUP] 1 [/SUP], Kensuke Nakagawara[SUP] 1 [/SUP], Mayuko Watase[SUP] 4 [/SUP], Katsunori Masaki[SUP] 1 [/SUP], Hirofumi Kamata[SUP] 1 [/SUP], Makoto Ishii[SUP] 1 [/SUP], Naoki Hasegawa[SUP] 3 [/SUP], Norihiro Harada[SUP] 5 [/SUP], Tetsuya Ueda[SUP] 6 [/SUP], Soichiro Ueda[SUP] 7 [/SUP], Takashi Ishiguro[SUP] 8 [/SUP], Ken Arimura[SUP] 9 [/SUP], Fukuki Saito[SUP] 10 [/SUP], Takashi Yoshiyama[SUP] 11 [/SUP], Yasushi Nakano[SUP] 12 [/SUP], Yoshikazu Mutoh[SUP] 13 [/SUP], Yusuke Suzuki[SUP] 14 [/SUP], Ryuya Edahiro[SUP] 15 [/SUP], Koji Murakami[SUP] 16 [/SUP], Yukinori Okada[SUP] 17 [/SUP], Ryuji Koike[SUP] 18 [/SUP], Yuko Kitagawa[SUP] 19 [/SUP], Katsushi Tokunaga[SUP] 20 [/SUP], Akinori Kimura[SUP] 21 [/SUP], Seiya Imoto[SUP] 22 [/SUP], Satoru Miyano[SUP] 23 [/SUP], Seishi Ogawa[SUP] 24 [/SUP], Takanori Kanai[SUP] 25 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP]; Japan COVID-19 Task Force



Affiliations
Abstract

We investigated the association between complete blood count, including neutrophil-to-lymphocyte ratio (NLR) in combination with patient characteristics, and coronavirus disease (COVID-19) outcomes to identify the best prognostic indicator. We analyzed data of patients with confirmed COVID-19 from the nationwide database of the Japan COVID-19 Task Force between February 2020 and November 2021. A composite outcome was defined as the most severe condition, including noninvasive positive-pressure ventilation, high-flow nasal cannula, invasive mechanical ventilation, extracorporeal membrane oxygenation, or death. Of 2425 patients in the analysis, 472 (19.5%) experienced a composite outcome. NLR was the best predictor of composite outcomes, with an area under the curve (AUC) of 0.81, and a sensitivity and specificity of 72.3% and 75.7%, respectively, using a cut-off value of 5.04. The combination of NLR and an oxygen requirement on admission had the highest AUC (0.88). This simple combination may help identify patients at risk of progression to severe disease.

Keywords: Area under the curve; COVID-19; Neutrophil-to-lymphocyte ratio; Prognostic indicator; SARS-CoV-2.

 
Back
Top Bottom